Rapid diagnosis of tuberculosis: laboratory techniques applicable in developing countries

Area of Science:

• Medical diagnostics
• Infectious disease research
• Tuberculosis (TB) diagnostics

Background:

• Tuberculosis (TB) remains a significant global health challenge, particularly in developing countries.
• Rapid and accurate diagnostic tools are crucial for effective TB control and treatment.
• Existing diagnostic methods often face limitations in resource-limited settings.

Purpose of the Study:

• To review emerging technologies for rapid tuberculosis diagnosis applicable in high-prevalence developing countries.
• To evaluate the potential of mycobacterial product detection and host response recognition methods.
• To assess the suitability of enzyme-linked immunosorbent assay (ELISA) and DNA/rRNA probe techniques for field application.

Main Methods:

• Immunoassays, specifically enzyme-linked immunosorbent assay (ELISA), for identifying mycobacterial antigens.
• Nucleic acid-based methods using single-stranded DNA probes to detect mycobacterial DNA or rRNA.
• Evaluation of serodiagnosis based on host IgG antibody response via ELISA.

Main Results:

• ELISA for antigen detection and DNA/rRNA probes are potentially suitable for developing countries, despite technical challenges with sputum samples.
• Serodiagnosis by ELISA shows promise for early application, contingent on the availability of specific antigens.
• The predictive accuracy of new diagnostic techniques requires comparison with direct microscopic sputum examination.

Conclusions:

• New diagnostic technologies offer potential for rapid tuberculosis detection in resource-limited settings.
• Serodiagnosis via ELISA is a promising approach, but antigen availability is critical for high specificity.
• Comparative accuracy studies against established methods are essential for validating novel TB diagnostic tools.